NOVAVAX INC
NOVAVAX INC
Insider Sentiment (TTM):
Last Purchase:2023-03-10Last Sale:2024-12-31Shares Purchased (TTM):0Shares Sold (TTM):0
Institutional Sentiment:
As of:2026-03-31Institutional Shares Owned:117,082,372Shares Outstanding:163,276,000Institutional Ownership Pct.:71.71%
Earnings Market Reaction:
Filing Date:2026-08-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 191 | 228 | 241 | 268 | 254 | 263 | 530 | 574 | 680 | 481 | 569 | 651 | |||||
Marketable Securities Current | 528 | 562 | 494 | 495 | 359 | 468 | 393 | 336 | 369 | - | 0 | - | |||||
Restricted Cash And Cash Equivalents At Carrying V… | 0 | 0 | 11 | 11 | 11 | 11 | 11 | 11 | 10 | 10 | 10 | 10 | |||||
Accounts Receivable Net | 19 | 23 | 106 | 34 | 226 | 45 | 108 | 95 | 32 | 21 | 297 | 124 | |||||
Inventory Net | 10 | 11 | 12 | 14 | 10 | 10 | 9 | 9 | 9 | 16 | 42 | 70 | |||||
Prepaid Expense And Other Assets Current | 23 | 26 | 27 | 46 | 60 | 71 | 78 | 80 | 102 | 199 | 226 | 152 | |||||
Assets Of Disposal Group Including Discontinued Op… | 0 | 0 | 88 | 108 | - | - | 0 | - | - | - | - | - | |||||
Assets Current | 771 | 851 | 978 | 975 | 920 | 868 | 1,129 | 1,104 | 1,203 | 727 | 1,144 | 1,007 | |||||
Property Plant And Equipment Net | 38 | 42 | 45 | 49 | 130 | 134 | 138 | 286 | 289 | 291 | 306 | 301 | |||||
Goodwill | 113 | 113 | 113 | 113 | 113 | 112 | 107 | 127 | 123 | 123 | 127 | 124 | |||||
Other Assets Noncurrent | 14 | 16 | 17 | 19 | 21 | 22 | 24 | 31 | 34 | 31 | 35 | 35 | |||||
Assets | 956 | 1,043 | 1,177 | 1,180 | 1,337 | 1,293 | 1,560 | 1,712 | 1,819 | 1,354 | 1,797 | 1,657 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 23 | 16 | 25 | 15 | 51 | 34 | 42 | 58 | 80 | 58 | 133 | 102 | |||||
Accrued Liabilities Current | 81 | 103 | 107 | 116 | 87 | 132 | 211 | 219 | 159 | 257 | 395 | 311 | |||||
Contract With Customer Liability Current | 87 | 89 | 140 | 104 | 114 | 108 | 675 | 613 | 666 | 241 | 241 | 192 | |||||
Convertible Notes Payable Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | |||||
Finance Lease Liability Current | - | 2 | 3 | 5 | 6 | 5 | 7 | 10 | 9 | 6 | 5 | 1 | |||||
Other Liabilities Current | 136 | 132 | 138 | 138 | 133 | 142 | 220 | 282 | 243 | 242 | 861 | 862 | |||||
Liabilities Of Disposal Group Including Discontinu… | 0 | 0 | 48 | 51 | - | - | 0 | - | - | - | - | - | |||||
Liabilities Current | 331 | 342 | 460 | 430 | 389 | 422 | 1,154 | 1,181 | 1,158 | 804 | 1,635 | 1,469 | |||||
Convertible Notes Payable | - | - | - | - | - | - | 170 | - | - | - | 168 | - | |||||
Contract With Customer Liability Noncurrent | 357 | 359 | 359 | 397 | 399 | 410 | 447 | 515 | 533 | 841 | 622 | 609 | |||||
Convertible Long Term Notes Payable | - | - | 244 | 244 | 171 | 170 | 170 | 169 | 169 | 168 | 168 | 168 | |||||
Long Term Debt | 291 | 291 | - | - | - | - | - | - | - | - | - | - | |||||
Finance Lease Liability Noncurrent | - | 2 | 2 | 2 | 52 | 53 | 54 | 54 | 55 | 55 | 56 | 53 | |||||
Other Liabilities Noncurrent | 166 | 193 | 239 | 263 | 288 | 314 | 360 | 319 | 335 | 352 | 33 | 37 | |||||
Liabilities | 1,146 | 1,188 | 1,304 | 1,337 | 1,299 | 1,369 | 2,184 | 2,239 | 2,250 | 2,221 | 2,514 | 2,336 | |||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | |||||
Additional Paid In Capital | 4,558 | 4,549 | 4,540 | 4,532 | 4,522 | 4,513 | 4,501 | 4,491 | 4,478 | 4,205 | 4,192 | 4,067 | |||||
Retained Earnings Accumulated Deficit | -4,631 | -4,578 | -4,568 | -4,586 | -4,383 | -4,490 | -5,008 | -4,927 | -4,806 | -4,969 | -4,821 | -4,643 | |||||
Treasury Stock Common Value | -112 | -112 | -103 | -103 | -102 | -102 | -96 | -95 | -94 | -94 | -92 | -92 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -7 | -5 | 2 | -2 | -0 | 2 | -23 | 4 | -11 | -11 | 3 | -12 | |||||
Stockholders Equity | -191 | -145 | -128 | -157 | 38 | -76 | -624 | -526 | -432 | -867 | -717 | -678 | |||||
Liabilities And Stockholders Equity | 956 | 1,043 | 1,177 | 1,180 | 1,337 | 1,293 | 1,560 | 1,712 | 1,819 | 1,354 | 1,797 | 1,657 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Preferred Stock Shares Authorized | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Common Stock Shares Authorized | 600 | 600 | 600 | 600 | 600 | 600 | 600 | 600 | 600 | 600 | 600 | 600 | |||||
Common Stock Shares Issued | 168 | 168 | 165 | 165 | 164 | 164 | 162 | 162 | 161 | 142 | 141 | 120 | |||||
Shares Outstanding | 165 | 164 | 163 | 162 | 162 | 162 | 160 | 160 | 160 | 140 | 140 | 119 | |||||
Treasury Stock Common Shares | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
0/5
Search a metric to start building a table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
0/1
Search a metric to start building a visual
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 17.20% | -5.13% | -20.30% | - | - | - | - | - | - | - | - | - |
| 2025 | 10.21% | -4.35% | 12.16% | -1.45% | 12.80% | 12.40% | -7.11% | -10.01% | 20.82% | -14.03% | -21.00% | -19.03% |
| 2024 | 69.26% | 42.57% | 92.68% | 5.99% | 13.87% | -16.61% | 5.67% | 4.61% | 2.72% | 7.65% | -15.01% | -4.67% |
| 2023 | - | - | - | 13.55% | 0.14% | -12.17% | -16.99% | -28.46% | -39.49% | 6.58% | -9.98% | 195.01% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 2.33 | 2.48 | 2.13 | 2.27 | 2.36 | 2.06 | 0.98 | 0.93 | 1.04 | 0.90 | 0.70 | 0.69 | |||||
| Quick Ratio | 2.23 | 2.38 | 2.04 | 2.13 | 2.18 | 1.86 | 0.90 | 0.86 | 0.94 | 0.64 | 0.54 | 0.53 | |||||
| Working Capital | 440.52M | 508.36M | 518.33M | 544.72M | 530.37M | 445.86M | -25.47M | -77.32M | 45.56M | -77.26M | -491.25M | -461.83M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -6.01 | -8.21 | -10.21 | -8.53 | 34.52 | -18.09 | -3.50 | -4.25 | -5.21 | -2.56 | -3.51 | -3.44 | |||||
| Interest Coverage TTM | -10.69 | -3.60 | 20.08 | 12.65 | 15.24 | 18.97 | -12.40 | -18.15 | -19.24 | -28.05 | -39.30 | -42.07 | |||||
| Debt Ratio | 1.20 | 1.14 | 1.11 | 1.13 | 0.97 | 1.06 | 1.40 | 1.31 | 1.24 | 1.64 | 1.40 | 1.41 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.36 | 0.51 | 0.82 | 0.74 | 0.68 | 0.95 | 0.41 | 0.53 | 0.56 | 0.69 | 0.49 | 0.53 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -1.51 | -0.54 | 2.54 | 2.10 | 2.39 | 2.69 | -1.23 | -1.78 | -1.77 | -2.85 | -5.41 | -5.31 | |||||
| Free Cash Flow Per Share TTM | -0.27 | -0.61 | -1.56 | -2.37 | -3.93 | -1.22 | -0.66 | -0.69 | -0.15 | -3.66 | -7.62 | -6.99 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 78.60% | 84.97% | 93.50% | 91.77% | 88.25% | 87.44% | 70.28% | 63.73% | 63.62% | 62.99% | 65.05% | 64.70% | |||||
| Operating Profit Margin TTM | -56.58% | -13.10% | 40.30% | 28.88% | 32.58% | 32.78% | -36.49% | -34.05% | -29.67% | -39.99% | -57.59% | -59.71% | |||||
| Net Profit Margin TTM | -59.87% | -14.73% | 39.19% | 32.10% | 39.20% | 38.14% | -27.49% | -32.18% | -29.80% | -40.01% | -55.41% | -52.29% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -61.64% | -52.48% | 64.69% | 20.27% | 9.22% | 25.92% | -30.65% | -15.68% | -38.17% | -26.66% | -50.36% | -43.15% | |||||
| Net Income Growth (1Y) | -158.59% | -118.35% | -334.83% | -219.97% | -243.65% | -220.06% | -65.60% | -48.11% | -49.84% | -65.49% | -17.16% | -58.48% | |||||
| EPS Growth (1Y) | -157.68% | -118.10% | -320.62% | -218.27% | -231.56% | -204.31% | -77.22% | -66.46% | -69.79% | -78.75% | -35.72% | -68.58% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -6.26 | -15.13 | 2.47 | 4.12 | 2.41 | 2.16 | -6.53 | -7.10 | -6.38 | -1.68 | -0.89 | -1.36 | |||||
| P/B TTM | -8.13 | -9.18 | -8.52 | -8.98 | 27.13 | -13.65 | -1.96 | -3.84 | -4.35 | -0.77 | -0.67 | -1.10 | |||||
| P/S TTM | 3.75 | 2.23 | 0.97 | 1.32 | 0.95 | 0.82 | 1.79 | 2.28 | 1.90 | 0.67 | 0.49 | 0.71 | |||||
| Market Cap | 1.55B | 1.33B | 1.09B | 1.41B | 1.02B | 1.03B | 1.22B | 2.02B | 1.88B | 668.80M | 483.69M | 748.83M | |||||
| Enterprise Value | 1.65B | 1.39B | 1.08B | 1.38B | 980.23M | 982.50M | 908.73M | 1.67B | 1.42B | 402.19M | 128.96M | 304.57M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -43.89M | -98.93M | -252.33M | -384.28M | -636.91M | -196.98M | -100.32M | -110.85M | -22.47M | -512.78M | -767.74M | -722.96M | |||||
| Net Debt | 95.45M | 58.11M | -7.24M | -32.22M | -40.49M | -49.82M | -314.87M | -355.28M | -462.31M | -266.60M | -354.73M | -444.25M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
2024-12-31Sale
Owner: Young, James F
Title: -
Shares: 5,400
Price/Share: $8.00
Value: $43,200.00
Shares Owned: 51,760
Relationship: Director
Ownership: Direct
2024-12-13Sale
Owner: King, Rachel K.
Title: -
Shares: 4,150
Price/Share: $9.02
Value: $37,433.00
Shares Owned: 14,770
Relationship: Director
Ownership: Direct
2024-06-21Sale
Owner: Young, James F
Title: -
Shares: 7,500
Price/Share: $14.09
Value: $105,675.00
Shares Owned: 61,760
Relationship: Director
Ownership: Direct
2024-06-18Sale
Owner: Young, James F
Title: -
Shares: 7,500
Price/Share: $13.95
Value: $104,625.00
Shares Owned: 69,260
Relationship: Director
Ownership: Direct
2024-06-17Sale
Owner: Dubovsky, Filip
Title: President, R&D
Shares: 13,904
Price/Share: $14.50
Value: $201,608.00
Shares Owned: 66,613
Relationship: Officer
Ownership: Direct
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
No data available for chart
2026-03-31
71.71%
Inst. Shares: 117,082,372
Shares Outstanding: 163,276,000
2025-12-31
71.41%
Inst. Shares: 115,674,818
Shares Outstanding: 161,991,000
2025-09-30
61.97%
Inst. Shares: 100,618,205
Shares Outstanding: 162,353,000
2025-06-30
61.04%
Inst. Shares: 98,900,435
Shares Outstanding: 162,019,000
2025-03-31
59.80%
Inst. Shares: 96,304,888
Shares Outstanding: 161,049,000
NOVAVAX INC (NVAX) — SEC Financial Statements & Analysis
NOVAVAX INC (NVAX) is a biological products, (no diagnostic substances) company, incorporated in DE. NOVAVAX INC trades on Nasdaq as: NVAX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), NOVAVAX INC reported a -61.64% year-over-year revenue growth, a Gross Profit Margin of 78.60% (TTM), a Debt-to-Equity ratio of -6.01x, a Price-to-Sales (P/S) ratio of 3.75x (TTM), a Price-to-Book (P/B) ratio of -8.13x (TTM), at a market cap of $1.55B. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -61.64%
- Gross Profit Margin TTM
- 78.60%
- Debt To Equity
- -6.01x
- P/S TTM
- 3.75x
- P/B TTM
- -8.13x
- Market Cap
- $1.55B
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is NOVAVAX INC in?
NOVAVAX INC (NVAX) operates in the Biological Products, (No Diagnostic Substances) industry.
What is NVAX's market cap?
NOVAVAX INC (NVAX) has a market capitalization of $1.55B as of 2026-06-30.
What exchange does NVAX trade on?
NOVAVAX INC (NVAX) trades on the Nasdaq.
Where is NOVAVAX INC incorporated?
NOVAVAX INC is incorporated in DE.